Tianjin Pharma's Indonesian JV a stepping stone to international expansion

While many big Chinese pharma companies are looking at the US market to take their first international steps, Tianjin Pharma, a state-owned group and the local partner in GlaxoSmithKline's joint venture in China, has decided to begin its planned global expansion in Southeast Asia.

More from Cardiovascular

More from Therapeutic Category